Alan Bradley

Alan Bradley

Founder at
Kymab Group Ltd.
66 year
Health Technology
Consumer Services
Finance

Profile

Allan Bradley is the founder of Spectral Genomics, Inc., founded in 2000.
Dr. Bradley is the founder of ExpressionEdits Ltd., founded in 2021.
Dr. Bradley is the founder of T-Therapeutics Ltd., founded in 2022, and holds the title Chief Scientific Officer & Director since 2025.
Dr. Bradley is also the founder of Lexicon Pharmaceuticals, Inc.,Kymab Group Ltd...
Dr. Bradley is an Independent Director at Sieger Healthcare Acquisition Corp.
Dr. Bradley is a Professor at the University of Cambridge.
Dr. Bradley was Executive Director at Wellcome Trust Sanger Institute.
Dr. Bradley was Professor at Baylor College of Medicine.
Dr. Bradley completed undergraduate, graduate, and doctorate degrees at the University of Cambridge.

Alan Bradley active positions

CompaniesPositionStart
Director/Board Member -
Founder -
Corporate Officer/Principal -

Former positions of Alan Bradley

CompaniesPositionEnd
Founder -
Corporate Officer/Principal -
LEXICON PHARMACEUTICALS, INC. Founder -
Director/Board Member -
Founder -
See the detail of Alan Bradley's experience

Training of Alan Bradley

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

76

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Finance

Commercial Services